Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction

Cell Host and Microbe

Volumn 11, Issue 4, 2012, Pages 337-351

  Meinzer, Ulrich ^a,b,c   Barreau, Frederick ^a,b   Esmiol Welterlin, Sophie ^d,h   Jung, Camille ^a,b,c   Villard, Claude ^e   Léger, Thibaut ^f   Ben Mkaddem, Sanah ^a,b   Berrebi, Dominique ^a,b,c   Dussaillant, Monique ^a,b   Alnabhani, Ziad ^a,b   Roy, Maryline ^b   Bonacorsi, Stéphane ^b,d,h   Wolf Watz, Hans ^g   Perroy, Julie ^h   Ollendorff, Vincent ^d,h   Hugot, Jean Pierre ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d University of Montpellier   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f INSTITUT JACQUES MONOD   (France)

^g UMEÅ UNIVERSITY   (Sweden)

^h UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; APOPTOSIS REGULATORY PROTEIN; BACTERIAL ENZYME; CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; RICK PROTEIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG; YOPJ PROTEIN;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSLOCATION; CATALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; INTESTINAL BARRIER DYSFUNCTION; INTESTINE MUCOSA PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; YERSINIA PSEUDOTUBERCULOSIS INFECTION;

ANIMALS; BACTERIAL PROTEINS; CASPASE 1; CELL LINE; FEMALE; HUMANS; INTESTINES; MALE; MAP KINASE KINASE KINASES; MICE; MICE, INBRED C57BL; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; SIGNAL TRANSDUCTION; YERSINIA PSEUDOTUBERCULOSIS; YERSINIA PSEUDOTUBERCULOSIS INFECTIONS;

EID: 84860001887     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2012.02.009     Document Type: Article

References (46)

1. Al-Sadi, R., Ye, D., Dokladny, K., and Ma, T.Y. (2008). Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J. Immunol. 180, 5653-5661.
2. Auerbuch, V., and Isberg, R.R. (2007). Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10. Infect. Immun. 75, 3561-3570. (Pubitemid 47040959)
3. Barreau, F., Meinzer, U., Chareyre, F., Berrebi, D., Niwa-Kawakita, M., Dussaillant, M., Foligne, B., Ollendorff, V., Heyman, M., Bonacorsi, S., et al. (2007). CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS ONE 2, e523.
4. Barreau, F., Madre, C., Meinzer, U., Berrebi, D., Dussaillant, M., Merlin, F., Eckmann, L., Karin, M., Sterkers, G., Bonacorsi, S., et al. (2010). Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches. Gut 59, 207-217.
5. Brodsky, I.E., and Medzhitov, R. (2008). Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence. PLoS Pathog. 4, e1000067.
6. Brodsky, I.E., Palm, N.W., Sadanand, S., Ryndak, M.B., Sutterwala, F.S., Flavell, R.A., Bliska, J.B., and Medzhitov, R. (2010). A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 7, 376-387.
7. Chen, C.M., Gong, Y., Zhang, M., and Chen, J.J. (2004). Reciprocal cross-talk between Nod2 and TAK1 signaling pathways. J. Biol. Chem. 279, 25876-25882. (Pubitemid 38756853)
8. Dorsch, M., Wang, A., Cheng, H., Lu, C., Bielecki, A., Charron, K., Clauser, K., Ren, H., Polakiewicz, R.D., Parsons, T., et al. (2006). Identification of a regulatory autophosphorylation site in the serine-threonine kinase RIP2. Cell. Signal. 18, 2223-2229. (Pubitemid 44636164)
9. Eckmann, L., and Karin, M. (2005). NOD2 and Crohn's disease: loss or gain of function? Immunity 22, 661-667. (Pubitemid 40814497)
10. Greten, F.R., Arkan, M.C., Bollrath, J., Hsu, L.C., Goode, J., Miething, C., Göktuna, S.I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007). NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130, 918-931. (Pubitemid 47332565)
11. Haase, R., Richter, K., Pfaffinger, G., Courtois, G., and Ruckdeschel, K. (2005). Yersinia outer protein P suppresses TGF-beta-activated kinase-1 activity to impair innate immune signaling in Yersinia enterocolitica-infected cells. J. Immunol. 175, 8209-8217. (Pubitemid 41798385)
12. Hsu, L.C., Ali, S.R., McGillivray, S., Tseng, P.H., Mariathasan, S., Humke, E.W., Eckmann, L., Powell, J.J., Nizet, V., Dixit, V.M., and Karin, M. (2008). A NOD2- NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. USA 105, 7803-7808. (Pubitemid 351872719)
13. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M., et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603. (Pubitemid 32531408)
14. Ibbotson, J.P., Lowes, J.R., Chahal, H., Gaston, J.S., Life, P., Kumararatne, D.S., Sharif, H., Alexander-Williams, J., and Allan, R.N. (1992). Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease. Clin. Exp. Immunol. 87, 224-230.
15. Jung, C., Hugot, J.P., and Barreau, F. (2010). Peyer's Patches: The Immune Sensors of the Intestine. Int. J. Inflam. 2010, 823710. Published online September 19, 2010. 10.4061/2010/823710.
16. Kallinowski, F., Wassmer, A., Hofmann, M.A., Harmsen, D., Heesemann, J., Karch, H., Herfarth, C., and Buhr, H.J. (1998). Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease. Hepatogastroenterology 45, 1552-1558. (Pubitemid 28515158)
17. Kim, J.Y., Kajino-Sakamoto, R., Omori, E., Jobin, C., and Ninomiya-Tsuji, J. (2009). Intestinal epithelial-derived TAK1 signaling is essential for cytoprotection against chemical-induced colitis. PLoS ONE 4, e4561.
18. Labow, M., Shuster, D., Zetterstrom, M., Nunes, P., Terry, R., Cullinan, E.B., Bartfai, T., Solorzano, C., Moldawer, L.L., Chizzonite, R., and McIntyre, K.W. (1997). Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159, 2452-2461. (Pubitemid 127681040)
19. Lahesmaa-Rantala, R., Magnusson, K.E., Granfors, K., Leino, R., Sundqvist, T., and Toivanen, A. (1991). Intestinal permeability in patients with yersinia triggered reactive arthritis. Ann. Rheum. Dis. 50, 91-94.
20. Lamps, L.W., Madhusudhan, K.T., Havens, J.M., Greenson, J.K., Bronner, M.P., Chiles, M.C., Dean, P.J., and Scott, M.A. (2003). Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease. Am. J. Surg. Pathol. 27, 220-227. (Pubitemid 36152232)
21. Lilo, S., Zheng, Y., and Bliska, J.B. (2008). Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ. Infect. Immun. 76, 3911-3923.
22. Marina-García, N., Franchi, L., Kim, Y.G., Miller, D., McDonald, C., Boons, G.J., and Núñez, G. (2008). Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2. J. Immunol. 180, 4050-4057.
23. Martinon, F., Agostini, L., Meylan, E., and Tschopp, J. (2004). Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14, 1929-1934. (Pubitemid 39464816)
24. Meinzer, U., Esmiol-Welterlin, S., Barreau, F., Berrebi, D., Dussaillant, M., Bonacorsi, S., Chareyre, F., Niwa-Kawakita, M., Alberti, C., Sterkers, G., et al. (2008). Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice. PLoS ONE 3, e2769.
25. Mittal, R., Peak-Chew, S.Y., and McMahon, H.T. (2006). Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. USA 103, 18574-18579. (Pubitemid 44913452)
26. Monack, D.M., Mecsas, J., Bouley, D., and Falkow, S. (1998). Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J. Exp. Med. 188, 2127-2137. (Pubitemid 28562529)
27. Mukherjee, S., Keitany, G., Li, Y., Wang, Y., Ball, H.L., Goldsmith, E.J., and Orth, K. (2006). Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312, 1211-1214. (Pubitemid 43801146)
28. Müller, A.J., Hoffmann, C., Galle, M., Van Den Broeke, A., Heikenwalder, M., Falter, L., Misselwitz, B., Kremer, M., Beyaert, R., and Hardt, W.D. (2009). The S. Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe 6, 125-136.
29. Nakagome, S., Mano, S., Kozlowski, L., Bujnicki, J.M., Shibata, H., Fukumaki, Y., Kidd, J.R., Kidd, K.K., Kawamura, S., and Oota, H. (2012). Crohn's Disease Risk Alleles on the NOD2 Locus Have Been Maintained by Natural Selection on Standing Variation. Mol. Biol. Evol. . Published online January 12, 2012.
30. Oppermann, F.S., Gnad, F., Olsen, J.V., Hornberger, R., Greff, Z., Kéri, G., Mann, M., and Daub, H. (2009). Large-scale proteomics analysis of the human kinome. Mol. Cell. Proteomics 8, 1751-1764.
31. Ragnarsson, E.G., Schoultz, I., Gullberg, E., Carlsson, A.H., Tafazoli, F., Lerm, M., Magnusson, K.E., Söderholm, J.D., and Artursson, P. (2008). Yersinia pseudotuberculosis induces transcytosis of nanoparticles across human intestinal villus epithelium via invasin-dependent macropinocytosis. Lab. Invest. 88, 1215-1226.
32. Saebo, A., Vik, E., Lange, O.J., and Matuszkiewicz, L. (2005). Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection. Eur. J. Intern. Med. 16, 176-182. (Pubitemid 40828255)
33. Saitoh, T., Fujita, N., Jang, M.H., Uematsu, S., Yang, B.G., Satoh, T., Omori, H., Noda, T., Yamamoto, N., Komatsu, M., et al. (2008). Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456, 264-268.
34. Serrander, R., Magnusson, K.E., Kihlström, E., and Sundqvist, T. (1986). Acute yersinia infections in man increase intestinal permeability for low-molecular weight polyethylene glycols (PEG 400). Scand. J. Infect. Dis. 18, 409-413. (Pubitemid 16017367)
35. Siegmund, B., Lehr, H.A., Fantuzzi, G., and Dinarello, C.A. (2001). IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation. Proc. Natl. Acad. Sci. USA 98, 13249-13254. (Pubitemid 33051348)
36. Singhirunnusorn, P., Suzuki, S., Kawasaki, N., Saiki, I., and Sakurai, H. (2005). Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J. Biol. Chem. 280, 7359-7368. (Pubitemid 40341294)
37. Stecher, B., Robbiani, R., Walker, A.W., Westendorf, A.M., Barthel, M., Kremer, M., Chaffron, S., Macpherson, A.J., Buer, J., Parkhill, J., et al. (2007). Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5, 2177-2189. (Pubitemid 350035420)
38. Sweet, C.R., Conlon, J., Golenbock, D.T., Goguen, J., and Silverman, N. (2007). YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Cell. Microbiol. 9, 2700-2715. (Pubitemid 47500520)
39. Tafazoli, F., Holmström, A., Forsberg, A., and Magnusson, K.E. (2000). Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria. Infect. Immun. 68, 5335-5343.
40. Thome, M., Hofmann, K., Burns, K., Martinon, F., Bodmer, J.L., Mattmann, C., and Tschopp, J. (1998). Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8, 885-888. (Pubitemid 28356050)
41. Viboud, G.I., and Bliska, J.B. (2005). Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59, 69-89. (Pubitemid 41507424)
42. Villani, A.C., Lemire, M., Fortin, G., Louis, E., Silverberg, M.S., Collette, C., Baba, N., Libioulle, C., Belaiche, J., Bitton, A., et al. (2009). Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 41, 71-76.
43. Windheim, M., Lang, C., Peggie, M., Plater, L.A., and Cohen, P. (2007). Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem. J. 404, 179-190. (Pubitemid 46849589)
44. Yu, Y., Ge, N., Xie, M., Sun, W., Burlingame, S., Pass, A.K., Nuchtern, J.G., Zhang, D., Fu, S., Schneider, M.D., et al. (2008). Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression. J. Biol. Chem. 283, 24497-24505.
45. Zhang, Y., and Bliska, J.B. (2010). YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection. Infect. Immun. 78, 2329-2341.
46. Zheng, Y., Lilo, S., Brodsky, I.E., Zhang, Y., Medzhitov, R., Marcu, K.B., and Bliska, J.B. (2011). A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. PLoS Pathog. 7, e1002026.